23 April 2003
Anti-phospholipid antibodies and carotid-artery intima-media thickness in young survivors of myocardial infarction.
Jerzy Dropiński, Wojciech Szczeklik, Paweł Rubiś, Wojciech J. SydorMed Sci Monit 2003; 9(4): BR105-109 :: ID: 4708
Abstract
BACKGROUND: Not all coronary events occur in young individuals with traditional risk factors. In recent years some authors have observed increased prevalence of elevated anti-phospholipid (aPL) antibodies in young patients with myocardial infarction. Also, thickening of the combined arterial intima-media thickness (IMT) of superficial vessels has been identified as an independent risk factor for both stroke and heart attack. The objective of our study was to assess possible association between aPL antibodies and carotid IM thickening in young survivors of myocardial MATERIAL/METHODS: In a case control study we determined IgG and IgM antiphospholipid antibodies by enzyme-immunoassay, and IMT by ultrasonography in 50 male survivors of myocardial infarction under the age of 50, and compared them to 50 healthy controls. RESULTS: Elevated aPL antibody levels (IgG>10 GPL; IgM>20MPL) were detected in 12 of 50 patients (24%) with MI and in 3 of 50 controls (6%). The mean level of aPL antibodies was significantly higher in the patients than in the controls (IgG 9.15+/-3.53 vs 7.69+/-2.98 GMP, p=0.04 and IgM 18.46+/-7.61 vs 12.14+/-5.05 MPL, p<0.01). Patients with MI had a significantly greater IMT than healthy controls (0.9 mm vs 0.6 mm; p<0.01). There was a correlation between aPL and IM thickening (r=0.31; p=0.01). Among coronary risk factors only hypertension (r=0.28; p=0.01) and smoking (r=0.41; p=0.01) showed a relationship with IMT. CONCLUSIONS: The intima-media thickness of the carotid artery and elevated aPL antibodies are strongly associated with the risk of myocardial infarction in young patients.
Keywords: Antibodies, Antiphospholipid - blood, Myocardial Infarction - blood, Myocardial Infarction - ultrasonography, Tunica Intima - ultrasonography, Tunica Media - ultrasonography
Editorial
01 March 2025 : Editorial
Editorial: The World Health Organization (WHO) Updated List of Emerging and Potentially Pandemic Pathogens Includes Yersinia pestis as Plague Vaccines Await Clinical TrialsDOI: 10.12659/MSM.948672
Med Sci Monit 2025; 31:e948672
In Press
Review article
Regulatory Efforts and Health Implications of Energy Drink Consumption by Minors in PolandMed Sci Monit In Press; DOI: 10.12659/MSM.947124
Review article
Current Trends and Innovations in Oral and Maxillofacial ReconstructionMed Sci Monit In Press; DOI: 10.12659/MSM.947152
Clinical Research
The Role of the Vojta Method in Diagnosing and Enhancing Motor Skills in Preterm Infants: A Prospective Ope...Med Sci Monit In Press; DOI: 10.12659/MSM.945495
Clinical Research
Comparative Outcomes of Robot-Assisted vs Traditional Laparoscopic Ureteral Reimplantation for Lower Ureter...Med Sci Monit In Press; DOI: 10.12659/MSM.946803
Most Viewed Current Articles
17 Jan 2024 : Review article 7,354,048
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research 702,440
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Mar 2024 : Editorial 27,976
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...DOI :10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
28 Jan 2024 : Review article 22,314
A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and FutureDOI :10.12659/MSM.943912
Med Sci Monit 2024; 30:e943912